U.S. markets open in 1 hour 37 minutes

  • S&P Futures

    3,772.75
    +7.25 (+0.19%)
     

  • Dow Futures

    30,922.00
    +44.00 (+0.14%)
     

  • Nasdaq Futures

    12,473.00
    +18.00 (+0.14%)
     

  • Russell 2000 Futures

    2,154.20
    +9.70 (+0.45%)
     

  • Crude Oil

    65.28
    +1.45 (+2.27%)
     

  • Gold

    1,692.20
    -8.50 (-0.50%)
     

  • Silver

    25.35
    -0.11 (-0.42%)
     

  • EUR/USD

    1.1936
    -0.0043 (-0.36%)
     

  • 10-Yr Bond

    1.5500
    0.0000 (0.00%)
     

  • Vix

    27.50
    +0.83 (+3.11%)
     

  • GBP/USD

    1.3816
    -0.0078 (-0.56%)
     

  • USD/JPY

    108.3540
    +0.3780 (+0.35%)
     

  • BTC-USD

    47,648.22
    -1,797.17 (-3.63%)
     

  • CMC Crypto 200

    952.50
    -34.71 (-3.52%)
     

  • FTSE 100

    6,678.87
    +27.99 (+0.42%)
     

  • Nikkei 225

    28,864.32
    -65.78 (-0.23%)
     
COMING UP:

Payroll gains likely accelerated in Feb. as restrictions eased

Check back for results at 8:30 a.m. ET

Global Wound Dressings Market to Reach $11.9 Billion by 2027

ReportLinker
·27 min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 7. - Influencer Pool: 1167. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 05, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Wound Dressings Industry" - https://www.reportlinker.com/p06033319/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.



Abstract:
- Global Wound Dressings Market to Reach $11.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Wound Dressings estimated at US$6.8 Billion in the year 2020, is projected to reach a revised size of US$11.9 Billion by 2027, growing at aCAGR of 8.4% over the period 2020-2027. Advanced, one of the segments analyzed in the report, is projected to record 8.7% CAGR and reach US$8.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Traditional segment is readjusted to a revised 7.8% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $1.8 Billion, While China is Forecast to Grow at 12.7% CAGR
- The Wound Dressings market in the U.S. is estimated at US$1.8 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2027 trailing a CAGR of 12.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 7.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Select Competitors (Total 36 Featured) -

  • 3M

  • Advanced Medical Solutions Group Plc

  • Advancis Medical

  • B. Braun Melsungen Ag

  • Cardinal Health

  • Coloplast A/S

  • Convatec Group Plc

  • Dermarite Industries, Llc

  • Deroyal Industries, Inc.

  • Hollister Incorporated.




Read the full report: https://www.reportlinker.com/p06033319/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Wound Dressings Competitor Market Share Scenario Worldwide
(in %): 2020E
Global Competitor Market Shares by Segment

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Wound Dressings by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 2: World Historic Review for Wound Dressings by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Wound Dressings by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Advanced by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 5: World Historic Review for Advanced by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Advanced by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Traditional by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Traditional by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Traditional by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Hospitals, ASCs &
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for Hospitals, ASCs & Clinics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for Hospitals, ASCs &
Clinics by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 16: World Current & Future Analysis for Home Care
Settings by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Home Care Settings by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Home Care Settings by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Surgical &
Traumatic Wounds by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Surgical & Traumatic Wounds
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Surgical & Traumatic
Wounds by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

Table 22: World Current & Future Analysis for Diabetic Foot
Ulcers by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Diabetic Foot Ulcers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 24: World 15-Year Perspective for Diabetic Foot Ulcers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Pressure Ulcers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Pressure Ulcers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Pressure Ulcers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Venous Leg Ulcers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 29: World Historic Review for Venous Leg Ulcers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Venous Leg Ulcers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Other Wound Types
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 32: World Historic Review for Other Wound Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Other Wound Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
Market Analytics
Table 34: USA Current & Future Analysis for Wound Dressings by
Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 35: USA Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 36: USA 15-Year Perspective for Wound Dressings by Type -
Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 37: USA Current & Future Analysis for Wound Dressings by
End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Wound Dressings by End-Use -
Other End-Uses, Hospitals, ASCs & Clinics and Home Care
Settings Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Wound Dressings by
Wound Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for Wound Dressings by Wound Type -
Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Pressure
Ulcers, Venous Leg Ulcers and Other Wound Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Wound Dressings by Wound
Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

CANADA
Table 43: Canada Current & Future Analysis for Wound Dressings
by Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 44: Canada Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 45: Canada 15-Year Perspective for Wound Dressings by
Type - Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Wound Dressings
by End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Wound Dressings by End-Use -
Other End-Uses, Hospitals, ASCs & Clinics and Home Care
Settings Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 49: Canada Current & Future Analysis for Wound Dressings
by Wound Type - Surgical & Traumatic Wounds, Diabetic Foot
Ulcers, Pressure Ulcers, Venous Leg Ulcers and Other Wound
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 50: Canada Historic Review for Wound Dressings by Wound
Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Wound Dressings by
Wound Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

JAPAN
Table 52: Japan Current & Future Analysis for Wound Dressings
by Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 53: Japan Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 54: Japan 15-Year Perspective for Wound Dressings by Type -
Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 55: Japan Current & Future Analysis for Wound Dressings
by End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Wound Dressings by End-Use -
Other End-Uses, Hospitals, ASCs & Clinics and Home Care
Settings Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 58: Japan Current & Future Analysis for Wound Dressings
by Wound Type - Surgical & Traumatic Wounds, Diabetic Foot
Ulcers, Pressure Ulcers, Venous Leg Ulcers and Other Wound
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 59: Japan Historic Review for Wound Dressings by Wound
Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Wound Dressings by
Wound Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

CHINA
Table 61: China Current & Future Analysis for Wound Dressings
by Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 62: China Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 63: China 15-Year Perspective for Wound Dressings by Type -
Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 64: China Current & Future Analysis for Wound Dressings
by End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Wound Dressings by End-Use -
Other End-Uses, Hospitals, ASCs & Clinics and Home Care
Settings Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 67: China Current & Future Analysis for Wound Dressings
by Wound Type - Surgical & Traumatic Wounds, Diabetic Foot
Ulcers, Pressure Ulcers, Venous Leg Ulcers and Other Wound
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 68: China Historic Review for Wound Dressings by Wound
Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Wound Dressings by
Wound Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

EUROPE
Market Facts & Figures
Market Analytics
Table 70: Europe Current & Future Analysis for Wound Dressings
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia and Rest of Europe Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027 and %
CAGR

Table 71: Europe Historic Review for Wound Dressings by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Wound Dressings by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 73: Europe Current & Future Analysis for Wound Dressings
by Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 74: Europe Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 75: Europe 15-Year Perspective for Wound Dressings by
Type - Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 76: Europe Current & Future Analysis for Wound Dressings
by End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Wound Dressings by End-Use -
Other End-Uses, Hospitals, ASCs & Clinics and Home Care
Settings Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 79: Europe Current & Future Analysis for Wound Dressings
by Wound Type - Surgical & Traumatic Wounds, Diabetic Foot
Ulcers, Pressure Ulcers, Venous Leg Ulcers and Other Wound
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 80: Europe Historic Review for Wound Dressings by Wound
Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Wound Dressings by
Wound Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

FRANCE
Table 82: France Current & Future Analysis for Wound Dressings
by Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 83: France Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 84: France 15-Year Perspective for Wound Dressings by
Type - Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 85: France Current & Future Analysis for Wound Dressings
by End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Wound Dressings by End-Use -
Other End-Uses, Hospitals, ASCs & Clinics and Home Care
Settings Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 88: France Current & Future Analysis for Wound Dressings
by Wound Type - Surgical & Traumatic Wounds, Diabetic Foot
Ulcers, Pressure Ulcers, Venous Leg Ulcers and Other Wound
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 89: France Historic Review for Wound Dressings by Wound
Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Wound Dressings by
Wound Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

GERMANY
Table 91: Germany Current & Future Analysis for Wound Dressings
by Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 92: Germany Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 93: Germany 15-Year Perspective for Wound Dressings by
Type - Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 94: Germany Current & Future Analysis for Wound Dressings
by End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Wound Dressings by
End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 97: Germany Current & Future Analysis for Wound Dressings
by Wound Type - Surgical & Traumatic Wounds, Diabetic Foot
Ulcers, Pressure Ulcers, Venous Leg Ulcers and Other Wound
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 98: Germany Historic Review for Wound Dressings by Wound
Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 99: Germany 15-Year Perspective for Wound Dressings by
Wound Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

ITALY
Table 100: Italy Current & Future Analysis for Wound Dressings
by Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 101: Italy Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 102: Italy 15-Year Perspective for Wound Dressings by
Type - Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 103: Italy Current & Future Analysis for Wound Dressings
by End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 104: Italy Historic Review for Wound Dressings by End-Use -
Other End-Uses, Hospitals, ASCs & Clinics and Home Care
Settings Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 105: Italy 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 106: Italy Current & Future Analysis for Wound Dressings
by Wound Type - Surgical & Traumatic Wounds, Diabetic Foot
Ulcers, Pressure Ulcers, Venous Leg Ulcers and Other Wound
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 107: Italy Historic Review for Wound Dressings by Wound
Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 108: Italy 15-Year Perspective for Wound Dressings by
Wound Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

UNITED KINGDOM
Table 109: UK Current & Future Analysis for Wound Dressings by
Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 110: UK Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 111: UK 15-Year Perspective for Wound Dressings by Type -
Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 112: UK Current & Future Analysis for Wound Dressings by
End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 113: UK Historic Review for Wound Dressings by End-Use -
Other End-Uses, Hospitals, ASCs & Clinics and Home Care
Settings Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 114: UK 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 115: UK Current & Future Analysis for Wound Dressings by
Wound Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 116: UK Historic Review for Wound Dressings by Wound Type -
Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Pressure
Ulcers, Venous Leg Ulcers and Other Wound Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 117: UK 15-Year Perspective for Wound Dressings by Wound
Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

SPAIN
Table 118: Spain Current & Future Analysis for Wound Dressings
by Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 119: Spain Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 120: Spain 15-Year Perspective for Wound Dressings by
Type - Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 121: Spain Current & Future Analysis for Wound Dressings
by End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 122: Spain Historic Review for Wound Dressings by End-Use -
Other End-Uses, Hospitals, ASCs & Clinics and Home Care
Settings Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 123: Spain 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Table 124: Spain Current & Future Analysis for Wound Dressings
by Wound Type - Surgical & Traumatic Wounds, Diabetic Foot
Ulcers, Pressure Ulcers, Venous Leg Ulcers and Other Wound
Types - Independent Analysis of Annual Sales in US$ Million for
the Years 2020 through 2027 and % CAGR

Table 125: Spain Historic Review for Wound Dressings by Wound
Type - Surgical & Traumatic Wounds, Diabetic Foot Ulcers,
Pressure Ulcers, Venous Leg Ulcers and Other Wound Types
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 126: Spain 15-Year Perspective for Wound Dressings by
Wound Type - Percentage Breakdown of Value Sales for Surgical &
Traumatic Wounds, Diabetic Foot Ulcers, Pressure Ulcers, Venous
Leg Ulcers and Other Wound Types for the Years 2012, 2020 &
2027

RUSSIA
Table 127: Russia Current & Future Analysis for Wound Dressings
by Type - Advanced and Traditional - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 128: Russia Historic Review for Wound Dressings by Type -
Advanced and Traditional Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 129: Russia 15-Year Perspective for Wound Dressings by
Type - Percentage Breakdown of Value Sales for Advanced and
Traditional for the Years 2012, 2020 & 2027

Table 130: Russia Current & Future Analysis for Wound Dressings
by End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings - Independent Analysis of Annual Sales in US$
Million for the Years 2020 through 2027 and % CAGR

Table 131: Russia Historic Review for Wound Dressings by
End-Use - Other End-Uses, Hospitals, ASCs & Clinics and Home
Care Settings Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 132: Russia 15-Year Perspective for Wound Dressings by
End-Use - Percentage Breakdown of Value Sales for Other
End-Uses, Hospitals, ASCs & Clinics and Home Care Settings for
the Years 2012, 2020 & 2027

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06033319/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Recommended Stories

  • U.K. House Prices Fell Again in February, Lender Halifax Says

    (Bloomberg) -- U.K. house prices fell for a second month in February during a national lockdown to control the coronavirus, the mortgage lender Halifax said.The 0.1% drop last month follows an 0.3% decline in January and brought the annual pace of house price inflation to 5.2%. The figures contrast with an index from Nationwide Building Society showing the value of homes increased unexpectedly last month.Buyers boosted prices last year after the Treasury granted a temporary break on taxes for purchases, a measure that earlier this week was extended until the end of June. That helped offset headwinds from the deepest economic slump in three centuries and a surge in unemployment.“Having enjoyed an extremely strong period of activity in the second half of last year, the housing market continued its softer start to 2021,” Russell Galley, managing director of Halifax, said in a statement. “The housing market has been at something of a crossroads at the start of this year.”“We would not expect the level of growth seen in house prices over the past yearto be sustained throughout 2021,” he said.The average home now costs 251,697 pounds ($292,275).For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Olympic Games Power Provider Agrees to $3.2 Billion Takeover

    (Bloomberg) -- Aggreko Plc, one of the world’s biggest suppliers of portable power generators, accepted a 2.3 billion-pound ($3.2 billion) bid from a private equity consortium.TDR Capital and I Squared Capital agreed to buy the business for 880 pence per share in cash, London-listed Aggreko said in a statement. The price represents a 39% premium to Aggreko’s closing price on Feb. 4, the day before their interest was first reported. The stock rose 1.8% to 905 pence shortly after the open of regular trading Friday.Aggreko offers rentals of power, heating and cooling equipment to clients in the energy, refining, construction and events industries. It has provided generators to the Glastonbury Festival, Britain’s marquee music event, as well as the 2018 Winter Olympic Games in South Korea.Bloomberg News reported Thursday that the private equity firms were nearing a firm offer for Aggreko following weeks of negotiations. Platinum Equity has also made a preliminary approach to Aggreko, though its interest was seen as less likely to translate into a deal, people with knowledge of the matter said.TDR and I Squared’s offer for Aggreko is in-line with expectations and unlikely to see competing bids, Andrew Nussey, a Peel Hunt analyst, wrote in a note. The acquisition is expected to be completed in the summer of this year.Bargain HuntingPrivate equity firms have been hunting for bargains among listed companies in the U.K. Blackstone Group Inc. and Global Infrastructure Partners teamed up last month on a deal to buy Signature Aviation Plc, an operator of private-jet bases, for $4.7 billion. Allied Universal Security Services LLC, which is backed by Warburg Pincus, has offered to take over British security firm G4S Plc for 3.8 billion pounds.TDR has been particularly active. It completed an acquisition last month of a controlling stake in Walmart’s U.K. grocery arm, Asda Group Ltd., together with Britain’s Issa brothers. In February, it approached Arrow Global Group Plc about a potential takeover bid valuing the London-listed alternative investment group at more than 540 million pounds.Morgan Stanley, Barclays Plc, Deutsche Bank AG, Goldman Sachs Group Inc., JPMorgan Chase & Co. and Bank of America Corp. are advising the private equity consortium. Aggreko is working with Centerview Partners, Citigroup Inc. and Jefferies Financial Group Inc.Barclays, Bank of America, Deutsche Bank, Goldman Sachs and Banco Santander SA are helping arrange debt to fund the transaction.(Updates with shares trading in the second paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • BOJ's Kuroda brushes aside chance of widening yield band at March review

    Bank of Japan Governor Haruhiko Kuroda said he saw no need to widen an implicit band set for its long-term interest rate target at a policy review in March, stressing the need to keep borrowing costs low to support a pandemic-ravaged economy. The BOJ caps the 10-year bond yield around zero under a policy dubbed yield curve control (YCC), and currently allows the benchmark yield to move 40 basis points around the target. Markets have been rife with speculation the BOJ would widen that band and allow yields to move higher, but Kuroda played down that possibility on Friday.

  • Bond Traders Drive Up Yields After Lack of Powell Pushback

    (Bloomberg) -- Traders in the $21 trillion U.S. Treasury market are sending a clear signal that they intend to keep pushing yields higher until they upend financial conditions sufficiently to spark action from the Federal Reserve.Ten-year yields climbed again on Friday, heading toward last week’s one-year high and undermining stocks, after Fed Chair Jerome Powell gave just a minor nod to the recent, abrupt surge in long-term borrowing costs. He stressed that officials are focused on the long road ahead before they achieve their policy goals.Even before Powell spoke, some strategists were predicting the global borrowing benchmark rate was on course to reach 2%, a mere 40 basis points above last week’s peak. With yields on the rise again, it may not be long before mortgage-related hedging kicks in and brings that target closer. Goldman Sachs Group Inc. boosted its year-end forecast for 10-year Treasury yields on Thursday to 1.90% from 1.50%.Friday’s February payrolls report now looms as the next catalyst. Yields have already soared more than a half-point this year as a cheerier outlook for growth and inflation led traders to bring forward how soon they see the Fed lifting its policy rate. Many strategists had expected Powell to try to more forcefully tamp down yields before the Fed’s black-out period ahead of its March 17 policy decision. With no such effort emerging, market participants are left to ponder where policy makers’ pain threshold may be.“In this environment yields can certainly continue to test higher,” said Jonathan Cohn, a strategist at Credit Suisse. “How far the Fed is willing to allow stock markets to fall -- which is the poor man’s version of thinking about broad financial conditions -- is a key question.”During an appearance in a Wall Street Journal webinar Thursday, Powell said the recent bond-market swings “caught my attention.” He said he’s monitoring financial conditions and would be “concerned by disorderly conditions in markets.”Ten-year yields added 8 basis points on the day to 1.56%, and continued to creep higher in Asia hours touching 1.58%, bringing into view last week’s one-year high of 1.61%. With yields at current levels, there have been fresh concerns of convexity-related hedging flow which can undermine liquidity conditions and further roil riskier assets. Stocks slumped Thursday, with the S&P 500 Index briefly erasing its 2021 gains.Powell said he’d be concerned if there were a “persistent tightening in financial conditions that threatens the achievement of our goals.” But he didn’t mention any actions the Fed might take to curtail the climb in yields, which has lifted mortgage rates and risks dimming a bright spot in an economy still on the mend from the pandemic.Wall Street strategists have mulled options the Fed could take to push down long-term yields including: extending the duration of its bond purchases, or implementing a so-called “twist” operation -- involving selling part of the Fed’s shorter-dated holdings in favor of long-term Treasuries.“If yields continue higher too quickly, then that could be a problem for the Fed,” said Mark Zandi, chief economist at Moody’s Analytics. “It might undermine asset prices, possibly causing a major correction in stock prices and a freezing up of the housing market. This is not our base case, but it’s a concern and a risk.”Meanwhile, a market proxy for the anticipated annual inflation rate for the next half-decade exceeded 2.5% this week for the first time since 2008 -- aided by climbing oil prices.Traders are now pricing in a full quarter-point Fed rate boost in the first quarter of 2023. The Fed itself has signaled it intends to keep policy steady at least through the end of that year.”Market participants are putting the Fed to the test and saying, ‘OK, given this spike in inflation, if it’s not transient then you’re going to have to act sooner,”’ Scott Minerd, global chief investment officer of Guggenheim Partners, said in a Bloomberg Television interview.(Updates with Friday’s yield move)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Tech Selloff Continued After Powell’s Speech

    Powell reiterated the Fed is unlikely to alter policy until it sees signs that the unemployment rate will drop significantly and that inflation will rise sustainably.

  • Stocks Tumble, Gold Dumps , Dollar Jumps Amid Treasury Yield Spike as Powell Signals Inflation is Ahead

    Powell and his policymakers have until March 17 to regain control of monetary policy or they could face a creditability issue.

  • GameStop spikes as investors eye cryptic tweet by shareholder

    GameStop shares closed up 6.4% at $131.93 after earlier hitting $147.87, their highest since a surge in the heavily shorted stock late last month. One analyst and some Twitter users pointed to a cryptic tweet by Ryan Cohen, a major shareholder of GameStop and founder of e-commerce firm Chewy.com, as a plausible reason for the move, although Reuters could not independently determine causation. The late afternoon rally in GameStop began roughly around the time that Cohen tweeted what appeared to be a screenshot with the puppet dog advertising mascot of Pets.com, a famous casualty of the dotcom bubble two decades ago.

  • 3 Beginner Crypto Trading Strategies Worth Exploring

    New to crypto trading but don't know how to get started? Here are 3 simple long-term strategies worth considering.

  • Tesla Stock Update: Meltdown in Tesla Beginning as Forecasted

    It appears the breakdown is underway, and this could turn into an outright collapse into mid-March.

  • Powell says current policy appropriate even as bond market turmoil has caught his eye

    Federal Reserve Chairman Jerome Powell on Thursday said he would be concerned if there was persistent tightening in U.S. financial conditions

  • Bitcoin Extends Losses as Powell Dents Inflation Hedge Appeal

    (Bloomberg) -- Bitcoin’s appeal as a hedge against inflation is being put to the test, with the largest cryptocurrency slumping along with other risk assets after Jerome Powell failed to ease investor concern about rising price pressures.The digital token fell as much as 6.7% and traded at about $47,900 as of 2:38 p.m. in New York, after the Federal Reserve chairman said he is monitoring financial conditions and would be “concerned” by disorderly markets, but stopped short of offering specific steps -- which sent Treasury yields higher and stocks lower.“Once it feels like the market is in risk-off mode, which it clearly is, because if you’re selling everything except for energy, that’s very risk-off,” said Arthur Hogan, chief market strategist at National Securities Corp. “It really doesn’t matter whether you are Bitcoin or Ark or semis or banks -- every thing’s being thrown over the transom.”Bitcoin surged to more than $58,000 last month, with advocates such as MicroStrategy Inc. Chief Executive Officer Michael Saylor touting the token as alternative to cash because of the risk of rising inflation from government and central bank stimulus. Shares of the enterprise software maker, which has purchased over 90,000 Bitcoins, tumbled as much as 17% on Thursday. Critics say Bitcoin is in a giant, stimulus-fueled bubble that’s destined to burst like the 2017 boom and bust cycle. Bitcoin slid 21% last week but is still up more than fivefold in the past year. For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Bitcoin Could Reach $1 Million or More, Kraken CEO Says

    (Bloomberg) -- As the leader of crypto exchange Kraken, Jesse Powell is bound to be bullish on Bitcoin. Yet he’s projecting a disruptive future that would stretch the imagination of even the most ardent crypto fans.In a Bloomberg Television interview, Powell said Bitcoin could reach $1 million in the next decade, adding that supporters say it could eventually replace all of the major fiat currencies.“We can only speculate, but when you measure it in terms of dollars, you have to think it’s going to infinity,” he said. “The true believers will tell you that it’s going all the way to the moon, to Mars and eventually, will be the world’s currency.”The CEO also said San Francisco-based Kraken is considering going public, possibly next year.Extreme predictions are nothing new in the world of Bitcoin, where adherents stand to profit from convincing a wider audience that crypto is a legitimate asset class, rather than a speculative fad. The dollar remains the world’s reserve currency and is the benchmark for global trade, though its value has softened in the past year.Powell said Bitcoin bulls see it one day exceeding the combined market cap of the dollar, euro and other currencies.The dollar “is only 50 years old and it’s already showing extreme signs of weakness, and I think people will start measuring the price of things in terms of Bitcoin,” he said.The digital currency slipped 3% in early U.S. trading on Thursday, hovering around $49,000. Prices have surged almost 600% since the start of 2020 on the back of wider mainstream adoption, with bulls seeing it as both an inflation hedge and speculative asset.Critics argue that Bitcoin is in a giant, stimulus-fueled bubble destined to burst like the 2017 boom and bust cycle.Kraken benefits from higher prices as it reaps fees from increased trading. Bloomberg reported last month that the exchange was in talks to raise new funding, which would double the company’s valuation to more than $10 billion.“Personally, I think $10 billion is a low valuation,” Powell said. “I wouldn’t be interested in selling shares at that price.”The CEO did acknowledge the potential for wild market swings, saying prices can “move up or down 50% on any given day.” That kind of volatility has long been one of the negatives of Bitcoin, relegating the market to one of speculation, rather than a means of doing business.“If you are buying into Bitcoin out of speculation, you should be committed to holding for five years,” Powell said. “You have to have strong convictions to hold.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Melvin Capital Dusts Off From GameStop Fiasco With 22% Gain

    (Bloomberg) -- Gabe Plotkin spent the first half of January defending his hedge fund’s portfolio from a Reddit mob, the second half trying to convince investors he can survive a 53% loss, and early February explaining to Congress what happened.Now with the public spectacle subsiding, the most concrete sign is emerging yet that his Melvin Capital Management might actually manage to thrive anew. After adjusting strategy, Plotkin pulled off an almost 22% gain in February, about eight times the return of the S&P 500.So starts the most arduous part of the 42-year-old hedge fund manager’s bid to climb out of the hole left by January’s clash, in which retail investors organized on social media to drive up stocks such as GameStop Corp. that Melvin and others had bet would fall. The episode cost his investors -- including billionaire Steve Cohen, Brown University and the Robin Hood Foundation -- more than $6 billion.But even with the rebound, Plotkin’s fund, which had $8 billion at the start of February, will need to produce an additional 75% gain for earlier clients before they break even and start paying fees again. Investors who have stuck by or piled into the firm are betting he’ll be able to do that given his track record, which ranked him as one of the best stock pickers until this year.Last month’s performance was especially welcome for investors who decided to pony up a collective $250 million at the beginning of February -- likely seeing it as an opportunity to increase their exposure to a hedge fund that had been closed to new capital. The firm now manages $10.9 billion, including February’s gain and money that came in on March 1.That vote of confidence followed a late-January investment by Ken Griffin, his partners and his Citadel hedge funds, and Cohen’s Point72 Asset Management, which together gave the firm $2.75 billion in exchange for a three-year minority piece of Melvin’s revenue. The deal came together in a matter of hours.Plotkin said in his testimony to the House Committee on Financial Services last month that Griffin had reached out to him, and that the cash injection was not an emergency bailout.People close to his backers say they doubled down because they have faith in his trading acumen and personally like Plotkin, who’s known as family-oriented and relatively nice in an industry that’s famously cutthroat.Modifying WagersHe’s also a confident risk-taker. Since his days at Cohen’s shop, Plotkin was known for taking big positions on the long and the short side. His recent performance suggests January’s rout hasn’t damaged his ability to make money.He did modify his wagers on stocks he expects to tumble, saying in his testimony that he would avoid crowded shorts. A person familiar with his strategy said he also will take smaller-sized positions to limit exposure to single companies. And Plotkin told his team of data scientists to scour social media and message boards to look for shares that retail investors are rallying around.He has stopped using exchange-traded puts that show up on his quarterly filings with the Securities and Exchange Commission -- clues that allowed his firm to be singled out by the Reddit crowd.Some hedge fund observers question whether Plotkin will still be able to produce blockbuster returns without chunky short positions. In Melvin’s first year of trading, 70% of the fund’s profits came from his bearish bets.Plotkin, who grew up in a middle-class family in Portland, Maine, didn’t have a flashy start to his money management career. Early on he landed at Griffin’s Citadel, hired to evaluate new businesses rather than taking a more coveted investment position. After a year, he jumped to Greenwich, Connecticut-based North Sound Capital, where he was a consumer stocks analyst for two years, with limited trading authority.Then, in 2006, he took a job at Cohen’s predecessor firm SAC Capital Advisors, and within five years was managing more than $1 billion in consumer-related stocks. Plotkin was among only a handful of managers at the firm with such a large portfolio, and was one of its highest paid professionals. He also would join Cohen on client visits to demonstrate SAC’s deep bench of talent.Cohen’s HelpInside SAC he was known for rigorous research of companies he invested in, former colleagues said. He used detailed models to analyze everything from cash flows to product demand, rather than relying on market information from brokers. He also was an early user of credit-card data.Plotkin announced he was leaving Cohen’s firm in early 2014 to start his own shop, just a few months after SAC pleaded guilty to securities fraud and paid a record fine to resolve charges in the U.S. government’s six-year crackdown on insider trading. Plotkin, who wasn’t accused of any wrongdoing, was among several senior portfolio managers to quit. As part of the settlement, Cohen would -- for a time -- only be managing his own money, thus reducing the amount of cash to be spread among portfolio managers.By that December, Plotkin was up and running at Melvin. He named the firm after his grandfather who ran a convenience store and had the work ethic and integrity he wanted do emulate in his own business. Plotkin raised close to $1 billion, including about $200 million from Cohen’s firm, now called Point72. His only down year was in 2018, when he lost 6%. The next two years his returns were around 50%.Overall, he posted annualized returns about 30% from his start in 2014 through last year.Plotkin declined to comment for this article, but during his House testimony, he signaled confidence that he will turn things around.“We’ll adapt,” he said. “The whole industry will have to adapt.”(Updates with inflow data in fifth paragraph and details of SAC role in fourteenth paragraph.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

  • Haryana's hiring rule spells disaster, industry group warns

    India's northern state of Haryana, where several automakers, component suppliers and big tech firms are based, faces an investment and development crisis from a new hiring rule to tackle high unemployment, lobby groups warned on Thursday. The Federation of Indian Chambers of Commerce and Industry (FICCI) said the policy, which requires 75% of all low to mid-paying private sector jobs to go to locals, would spell disaster for Haryana's "industrial development and private investment". The 10-year rule, applicable to jobs paying up to 50,000 rupees ($690) a month, came into effect this week in the state as it faces worsening unemployment as a result of the coronavirus crisis.

  • Indian IT isn’t hung up on the H-1B visa

    Even as Indian tech workers make up the bulk of H-1B recipients, it's not Indian companies that are hiring them.

  • Texas watchdog says grid operator made $16-billion error

    A firm hired to monitor Texas' power markets says the region's grid manager overpriced electricity over two days during last month's energy crisis, resulting in $16 billion in overcharges.

  • Galaxy Digital, CoinShares Back Bitcoin Mining Intermediary Startup

    Compass raised $1.7 million from a cadre of cryptocurrency businesses and investors.

  • Why UK finance minister Rishi Sunak put a “super-deduction” in his budget

    British companies are sitting on mountains of cash, stockpiled through the uncertainty of Brexit and the pandemic. Sunak wants them to spend it.

  • OPEC, Russia send oil price up with deal to contain output

    Caution about the pandemic took the upper hand Thursday at a meeting of the OPEC oil cartel and allied countries, as they left most of their production cuts in place amid worry that coronavirus restrictions could still undermine recovering demand for crude. Many analysts had expected a small production increase as the price of oil has risen 30% since the start of the year on hopes that the pandemic will ease, allowing for an economic rebound that should increase energy consumption. Instead, the group of oil producers opted for caution, and their decision in favor of supply restraint quickly sent crude oil prices even higher.

  • Huobi Said to Be Launching Bitcoin, Ether Funds After Being Granted Hong Kong License

    The new license allows Huobi to advise on and manage securities investments.